The Council on Alcohol and Drugs, Inc. – Trademark Portfolio

Entity Type: 03

The Council on Alcohol and Drugs, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. The owner is based in Atlanta, GA.

270 Peachtree Street NW, Suite 2200

Atlanta, GA 30303

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

The Council on Alcohol and Drugs, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (3 filings)

Education; providing of training; entertainment; sporting and cultural activities

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does The Council on Alcohol and Drugs, Inc. have?

The Council on Alcohol and Drugs, Inc. has 4 U.S. trademarks filed with the USPTO.

What trademark classes does The Council on Alcohol and Drugs, Inc. file in?

The Council on Alcohol and Drugs, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What is The Council on Alcohol and Drugs, Inc.'s trademark registration success rate?

The Council on Alcohol and Drugs, Inc. has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.